A detailed history of Assetmark, Inc transactions in Elanco Animal Health Inc stock. As of the latest transaction made, Assetmark, Inc holds 127 shares of ELAN stock, worth $1,783. This represents 0.0% of its overall portfolio holdings.

Number of Shares
127
Previous 31 309.68%
Holding current value
$1,783
Previous $0 Infinity%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

BUY
$11.85 - $15.47 $1,137 - $1,485
96 Added 309.68%
127 $1,000
Q2 2024

Aug 13, 2024

SELL
$12.93 - $18.45 $25 - $36
-2 Reduced 6.06%
31 $0
Q1 2024

May 06, 2024

BUY
$14.37 - $16.46 $244 - $279
17 Added 106.25%
33 $0
Q4 2023

Feb 09, 2024

BUY
$8.6 - $14.94 $137 - $239
16 New
16 $0
Q2 2021

Aug 16, 2021

BUY
$28.76 - $35.98 $517 - $647
18 New
18 $1,000

Others Institutions Holding ELAN

About Elanco Animal Health Inc


  • Ticker ELAN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 474,113,984
  • Market Cap $6.66B
  • Description
  • Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...
More about ELAN
Track This Portfolio

Track Assetmark, Inc Portfolio

Follow Assetmark, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Assetmark, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Assetmark, Inc with notifications on news.